Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

CSL Behring reports positive Phase III PROLONG-9FP trial data of IDELVION to treat haemophilia B

Go Top